Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ASRT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ASRT

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Assertio Therapeutics Inc

ASRT
Current price
0.67 USD +0.003 USD (+0.45%)
Last closed 0.68 USD
ISIN US04546C2052
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 65 140 460 USD
Yield for 12 month -58.96 %
1Y
3Y
5Y
10Y
15Y
ASRT
21.11.2021 - 28.11.2021

Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois. Address: 100 South Saunders Road, Lake Forest, IL, United States, 60045

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.80 USD

P/E Ratio

Dividend Yield

Financials ASRT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ASRT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+124 961 000 USD

Last Year

+152 069 000 USD

Current Quarter

+26 488 000 USD

Last Quarter

+32 182 000 USD

Current Year

+85 734 000 USD

Last Year

+125 049 000 USD

Current Quarter

+18 702 000 USD

Last Quarter

+20 571 000 USD
EBITDA -608 000 USD
Operating Margin TTM -48.87 %
Price to Earnings
Return On Assets TTM -6.60 %
PEG Ratio 1.50
Return On Equity TTM -25.19 %
Wall Street Target Price 2.80 USD
Revenue TTM 119 001 000 USD
Book Value 1.13 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -18.40 %
Dividend Yield
Gross Profit TTM 83 165 000 USD
Earnings per share -0.32 USD
Diluted Eps TTM -0.32 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -18.80 %
Profit Margin -25.72 %

Stock Valuation ASRT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 14.99
Enterprise Value Revenue 0.15
Price Sales TTM 0.55
Enterprise Value EBITDA 11.69
Price Book MRQ 0.61

Technical Indicators ASRT

For 52 Weeks

0.51 USD 1.70 USD
50 Day MA 0.66 USD
Shares Short Prior Month 5 774 147
200 Day MA 0.82 USD
Short Ratio 24.92
Shares Short 5 861 414
Short Percent 6.08 %